Profilinstitute.com

Over the last three years, pharmaceutical companies have mounted a public relations blitz to tout new cures for the hepatitis C virus and persuade insurers, including government programs such as Medicare and Medicaid, to cover the costs. That isn’t an...

As part of the LDN 2017 Conference we are proud to offer the recorded presentation as outlined below. Cancer: Using the Latest Ideas in Immunotherapy to Improve Outcomes, Survival, and Quality of Life 30m  Paul Anderson, NMD Cancer is a pervasive...

(Fast Company) – It would raise the stakes even higher, but that didn’t stop Jay Flatley,Illumina’s then chief executive, from sending in vials of his own saliva and blood to the company’s newly opened lab. It was January 2009, and Illumina’s scientists...

Today’s compendium of economic, political, and environmental events is a doozy. Starting with a taper at home we cover the latest developments in Europe, the Greek meltdown, Ukrainian angst and Russian manuvers, Latin American politics, Indian...

Big support for UN Access to Medicines High Level Panel’s Report There is an urgent need not only to support but to undertake follow up activities relating to the recently released report of the UN Secretary General’s high level panel on access to medicines...